investorscraft@gmail.com

Intrinsic Value of Amryt Pharma PLC Sponsored ADR (AMYT)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %21.9NaN
Revenue, $223NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m261NaN
Operating income, $m-39NaN
EBITDA, $m17NaN
Interest expense (income), $mNaN
Earnings before tax, $m-7NaN
Tax expense, $m-8NaN
Net income, $m1NaN

BALANCE SHEET

Cash and short-term investments, $m113NaN
Total assets, $m816NaN
Adjusted assets (=assets-cash), $m703NaN
Average production assets, $m432NaN
Working capital, $m125NaN
Total debt, $m201NaN
Total liabilities, $m459NaN
Total equity, $m357NaN
Debt-to-equity ratio0.563NaN
Adjusted equity ratio0.349NaN

CASH FLOW

Net income, $m1NaN
Depreciation, amort., depletion, $m55NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m16NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m16NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m125
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount